Brazilian Fish has set out its plans to use the latest genetic technology to improve its farmed tilapia, with the help of US specialist the Center for Aquaculture Technologies (CAT).
Genome editing – also known as gene editing – precisely targets and accelerates genetic changes that would naturally occur.
Brazilian Fish is the third largest tilapia producer in the country, and exports to Japan, Taiwan and the USA. The company’s partnership with CAT will focus on performing genome editing on specific genetic regions of interest in Nile tilapia.
The company said that the technology used would allow a 20-year breeding programme to be completed in one year.